Advancing medical research and product development
Teewinot Life Sciences is a global biopharmaceutical company focused on the biosynthetic production of pure pharmaceutical grade cannabinoids. Teewinot has developed patent protected processes for production of pure cannabinoids by means of biocatalysis and synthetic biology. Teewinot has also developed patent protected cannabinoid formulation technology all with the goal of improving human therapies. Headquartered in Tampa, Florida, Teewinot manufactures and licenses technology to make cost-effective and pharmaceutically pure cannabinoids. We are an industry leader in support of advancing medical research and product development. Teewinot’s global technology and intellectual property represent a breakthrough in the creation and delivery of cannabinoid-based medicines.
Teewinot and its wholly owned subsidiaries have developed a variety of products and services that rely on a powerful array of technologies for the efficient and cost-effective production of authentic cannabinoids, cannabinoid pro-drugs and cannabinoid analogs. By combining synthetic biology, biocatalysis, chemical synthesis, bioinformatics and metabolomics, authentic cannabinoids are produced that have the identical chemical structure of cannabinoids found in the Cannabis plant. These same technologies are also used to create novel and proprietary compounds, including cannabinoid pro-drugs and cannabinoid analogs.
Watch Our Video
Meet the Teewinot Team
The people behind Teewinot
Teewinot has assembled a veteran management team with demonstrated success in pharmaceutical development, nutraceutical product development, marketing, supply chain management and after-market support.
Charles Brink, JD
Chief Executive Officer, President, & Chairman
Chief Financial Officer
Dr. Malcolm Kavarana
Chief Scientific Officer & Senior Director Intellectual Property
Richard Peet, JD, Ph.D.
Executive Vice President & Chief Intellectual Property Counsel
Eric A. Walker
Chief Information Officer